Sökning: onr:"swepub:oai:DiVA.org:uu-350630" >
Loss in working yea...
Loss in working years after a breast cancer diagnosis
-
- Plym, Anna (författare)
- Karolinska Institutet
-
- Bower, Hannah (författare)
- Karolinska Institutet
-
- Fredriksson, Irma (författare)
- Karolinska Institutet
-
visa fler...
-
- Holmberg, Lars (författare)
- Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London SE1 9RT, England.
-
- Lambert, Paul C. (författare)
- Karolinska Institutet
-
- Lambe, Mats (författare)
- Karolinska Institutet,Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden
-
visa färre...
-
Karolinska Institutet Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London SE1 9RT, England (creator_code:org_t)
- 2018-01-23
- 2018
- Engelska.
-
Ingår i: British Journal of Cancer. - : NATURE PUBLISHING GROUP. - 0007-0920 .- 1532-1827. ; 118:5, s. 738-743
- Relaterad länk:
-
https://www.nature.c...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Breast cancer can negatively influence working life, but it is unclear how many working years women with breast cancer can expect to lose. Methods: Women diagnosed with breast cancer between 1997 and 2012 were identified in the Breast Cancer Data Base Sweden (N = 19 661), together with breast cancer-free comparison women (N = 81 303). Using flexible parametric survival modelling, the loss in working years was calculated as the difference in the remaining years in the work force between women with and without breast cancer. Results: Women aged 50 years at diagnosis with stage I disease lost on average 0.5 years (95% CI, 0.2-0.7) of their remaining working time; the corresponding estimates were 0.9 years (0.5-1.2) in stage II, 2.5 years (1.9-3.1) in stage III and 8.1 years (6.5-9.7) in stage IV. Women with in situ breast cancer did not lose any working years. The strongest treatment determinant was axillary lymph node dissection. Conclusions: We found a loss in working years not only in late but also in early-stage breast cancer. Although it is reassuring that some groups had no or only a modest work loss, the economic consequences for society are considerable given the large number of women annually diagnosed with breast cancer.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- breast cancer
- employment
- disability pension
- retirement
- sick leave
- Sweden
- survival
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas